Atlas Trials

Prevention of Meningococcal Infection

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Prevention of Meningococcal Infection

RecordFirmDate
Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine (NCT00310713)Novartis Vaccines2006-04-01
Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children (NCT00311415)Novartis Vaccines2005-10-01
Kinetics of B Cell Response in Infants Menjugate Vaccination (NCT00310700)Novartis2005-05-01
Persistence of Antibody Response to N. Meningitidis Group C in Children (NCT00316654)Novartis Vaccines2005-02-01
Persistence of Immune Response After Vaccination With MCC (NCT00310687)Novartis2004-10-01
Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age (NCT00310674)Novartis2004-09-01

Track Prevention of Meningococcal Infection automatically

Every clearance here is in the API, with alerts when new ones post.